A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
Pharmaceutical Commerce - March 2021
Catchphrase or not, the patient journey is seemingly more complex than ever these days—upping the ante for new strategies in specialty-care support
2020 was a difficult year for many patients, but new data may signal a brighter future ahead
A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb
Non-commercial pharmacies can be secret weapons for intake and adherence
Their promise is prompting pharma leaders to give their hub/PAP CRM platforms a closer look
The key trends and considerations for specialty providers navigating a changing policy landscape
More leverage for community-based pharmacies and rules changes for drug-pricing reporting
Case study on closing the gap between new specialty drugs and specialty pharmacies
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
2
Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis
3
Strive Pharmacy Breaks Ground on Arizona HQ
4
CNPV Limits May Not Slow Collaboration or Commercialization
5
